COVID Risk | Literature database and meta-analysis page 16

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
SARS COV-2 infection	Symptoms	Fever [Present vs. Not present]	Odds ratio: 2.400 (1.100-5.000) ^§	Roland
SARS COV-2 infection	Symptoms	Shortness of breath [Present vs. Not present]	Odds ratio: 0.200 (0.100-0.400) ^§	Roland
SARS COV-2 infection	Symptoms	Smell or taste change [Present vs. Not present]	Odds ratio: 6.800 (3.900-12.000) ^§	Roland
Virus clearance	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Odds ratio: 2.370 (0.130-44.530)	Sharma
COVID-19 (severe/fatal)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Odds ratio: 1.370 (0.090-21.970)	Sharma
COVID-19 (severe/critical)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Odds ratio: 0.310 (0.110-0.900)	Sharma
COVID-19 (survival)	Complications	Initial ECG rhythm [Asystole vs. VF/VT]	Odds ratio: 0.010 (0.000-0.160) ^§	Shao
COVID-19 (survival)	Complications	Initial ECG rhythm [PEA vs. VF/VT]	Odds ratio: 0.140 (0.010-3.480) ^§	Shao
COVID-19 (survival)	Complications	Aetiology of cardiac arrest [Other causes vs. Cardiac]	Odds ratio: 0.640 (0.020-22.060) ^§	Shao
COVID-19 (survival)	Complications	Aetiology of cardiac arrest [Respiratory causes vs. Cardiac]	Odds ratio: 0.230 (0.020-2.470) ^§	Shao
COVID-19 (survival)	Other	Witness at cardiac arrest occurence [Yes vs. No]	Odds ratio: 0.250 (0.010-5.570) ^§	Shao
COVID-19 (survival)	Other	Location of cardiac arrest occurrence [ICU vs. General ward]	Odds ratio: 16.800 (1.663-169.700) ^§	Shao
COVID-19 (survival)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 4.280 (0.220-82.710) ^§	Shao
COVID-19 (survival)	Patient characteristics	Age [>60 years vs. <=60 years]	Odds ratio: 0.280 (0.020-4.090) ^§	Shao
COVID-19 (severe/fatal)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 1.320 (0.800-2.180) ^§	Mehta
COVID-19 (severe/fatal)	Treatment	Concomitant medication [Treated with ARBs vs. Not received]	Odds ratio: 1.120 (0.590-2.120) ^§	Mehta
COVID-19 (severe/fatal)	Treatment	Concomitant medication [Treated with ACEi vs. Not received]	Odds ratio: 1.350 (0.740-2.470) ^§	Mehta
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 1.640 (1.070-2.510) ^§	Mehta
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with ARBs vs. Not received]	Odds ratio: 1.160 (0.670-2.020) ^§	Mehta
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with ACEi vs. Not received]	Odds ratio: 1.770 (1.070-2.920) ^§	Mehta
COVID-19 (any condition)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 1.930 (1.380-2.710) ^§	Mehta
COVID-19 (any condition)	Treatment	Concomitant medication [Treated with ARBs vs. Not received]	Odds ratio: 1.610 (1.040-2.500) ^§	Mehta
COVID-19 (any condition)	Treatment	Concomitant medication [Treated with ACEi vs. Not received]	Odds ratio: 1.840 (1.220-2.790) ^§	Mehta
SARS COV-2 infection	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 0.970 (0.810-1.150) ^§	Mehta
SARS COV-2 infection	Treatment	Concomitant medication [Treated with ARBs vs. Not received]	Odds ratio: 1.090 (0.870-1.370) ^§	Mehta
SARS COV-2 infection	Treatment	Concomitant medication [Treated with ACEi vs. Not received]	Odds ratio: 0.890 (0.720-1.100) ^§	Mehta
COVID-19 (severe/fatal)	Comorbidities	Lung Disease [Present vs. Not present]	Odds ratio: 0.760 (0.200-2.860) ^§	Kalligeros
COVID-19 (severe/fatal)	Comorbidities	Heart disease [Present vs. Not present]	Odds ratio: 3.410 (1.050-11.060) ^§	Kalligeros
COVID-19 (severe/fatal)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 0.470 (0.130-1.660) ^§	Kalligeros
COVID-19 (severe/fatal)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 2.130 (0.730-6.220) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 9.990 (1.390-71.690) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 6.850 (1.050-44.820) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 3.700 (0.600-22.870) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 1.130 (0.320-3.400) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	Ethnicity [Hispanic vs. Non-Hispanic White]	Odds ratio: 1.170 (0.360-3.820) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	Ethnicity [Non-Hispanic Black vs. Non-Hispanic White]	Odds ratio: 1.830 (0.550-6.110) ^§	Kalligeros
COVID-19 (severe/fatal)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.020 (0.980-1.060) ^§	Kalligeros
COVID-19 (severe/critical)	Comorbidities	Lung Disease [Present vs. Not present]	Odds ratio: 1.500 (0.470-4.820) ^§	Kalligeros
COVID-19 (severe/critical)	Comorbidities	Heart disease [Present vs. Not present]	Odds ratio: 1.520 (0.510-4.510) ^§	Kalligeros
COVID-19 (severe/critical)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 0.790 (0.270-2.280) ^§	Kalligeros
COVID-19 (severe/critical)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 1.910 (0.710-5.190) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	BMI [Severe obesity (>35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 5.390 (1.130-25.640) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	BMI [Obesity (30-35kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 2.650 (0.640-10.950) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	BMI [Overweight (25-29kg/m2) vs. Normal (<25 kg/m2)]	Odds ratio: 2.270 (0.590-8.830) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 2.400 (0.870-6.640) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	Ethnicity [Hispanic vs. Non-Hispanic White]	Odds ratio: 0.560 (0.190-1.580) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	Ethnicity [Non-Hispanic Black vs. Non-Hispanic White]	Odds ratio: 0.800 (0.260-2.450) ^§	Kalligeros
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.030 (1.000-1.070) ^§	Kalligeros
SARS COV-2 infection	Other	Exposure-period with infected persons in households [0-1 day vs. >1 day]	Odds ratio: 0.900 (0.610-1.330) ^§	Li
SARS COV-2 infection	Other	Symptoms of infected persons in households [No cough vs. Cough]	Odds ratio: 0.880 (0.470-1.640) ^§	Li

If a relevant publication escaped our attention, please contact us.